Blog

The Real Reason Behind U.S. Oil Fund's Huge Strategic Shift

Stock market investors have seen huge swings in share prices across just about every sector of the economy as businesses come to grips with the realities of the coronavirus pandemic. The energy

TheMotleyFool

0

What to Do If Your Stimulus Check Amount Is Wrong

COVID-19 has forced millions of Americans into unemployment and shuttered small businesses across the country. Recognizing the need for relief, lawmakers passed the CARES (Coronavirus Aid, Relief

TheMotleyFool

0

Safeguard Scientifics Inc (SFE) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool.

Safeguard Scientifics Inc (NYSE: SFE)Q1 2020 Earnings CallApr 30, 2020, 9:00 a.m. ET

Operator

Source Fool.com

TheMotleyFool

0

3 Big Stories in Gilead Sciences' Q1 Results

It's unusual for Gilead Sciences' (NASDAQ: GILD) quarterly update to be the third-biggest story for the company. But that's exactly what happened this week.

Gilead announced its first-quarter

TheMotleyFool

0

The Movie Theater Industry Can't Afford the Fight AMC Just Picked

The sentiment is understandable. Movie theaters helped movie studios become the successes they are today, and it would be nice if studios worked to maintain the symbiotic relationship.

However, AMC

TheMotleyFool

0

Has Biogen Found the Answer to Treating Alzheimer's?

For years, we've seen the failure of clinical trials targeting Alzheimer's disease based on a controversial hypothesis. Biogen's (NASDAQ: BIIB) aducanumab may become the newest addition to the list

TheMotleyFool

0

Inovio Is in a Race to Develop a COVID-19 Vaccine, but Can It Possibly Win?

Inovio Pharmaceuticals (NASDAQ: INO) made waves in February when it announced it had produced a COVID-19 vaccine candidate after only three hours of effort. As with other companies announcing

TheMotleyFool

0

3 Tax Moves to Make Amid the COVID-19 Pandemic

With COVID-19 dominating the news, it's easy to let tax matters fall by the wayside -- especially if you're worried about losing your job or are struggling with the logistical ramifications of

TheMotleyFool

0

The Cost to Fix Social Security Rose $2.9 Trillion in 2020

As some of you may be aware, the nation's most successful social program is barreling toward serious trouble.

Despite paying out benefits without fail for more than 80 years, the Social Security

TheMotleyFool

0

Is Fiserv Stock a Buy?

Fiserv (NASDAQ: FISV) has been on a great run over the past decade. The financial technology company has seen its stock price rise 11 straight years, and it's delivered a sparkling 23% annualized

TheMotleyFool

0

3 Ways Your Stimulus Money Can Be Seized

Over the past two months, the coronavirus disease 2019 (COVID-19) has reshaped American societal habits. With the number of U.S. confirmed cases topping 1 million earlier this week, most states have

TheMotleyFool

0

What Does Remdesivir's Promising Study Mean for Gilead's Stock?

Results from an interim analysis of COVID-19 patients receiving Gilead Sciences' (NASDAQ: GILD) antiviral drug Remdesivir in phase 3 clinical trials conducted by the National Institute of Allergy

TheMotleyFool

0